Advertisement
Open Lending Corporation

LPRO News Today: Stay Updated with the Latest Open Lending Corporation News in Real Time

Find LPRO news now at Meyka AI. Stay informed with the latest Open Lending Corporation stocks updates, including price news, market analysis, and expert insights.

LPRONASDAQ
Financial ServicesFinancial - Credit Services
$2.13
$0.02(1.18%)
U.S. Market is Open · 13:27
Advertisement
Japan Cycling Association Chief Arrested for 30M Yen Fraud, June 11
📅 in about 4 hours

Japan Cycling Association Chief Arrested for 30M Yen Fraud, June 11

Japan Cycling Association director arrested for defrauding investors of 30 million yen through a fake electric vehicle patent investment scheme.

Read more 12
US Coast Guard Ends Bahamas Search for Missing Sailor Lynette Hooker, June 10
📅 in about 4 hours

US Coast Guard Ends Bahamas Search for Missing Sailor Lynette Hooker, June 10

US Coast Guard ends search for missing sailor Lynette Hooker in Bahamas. Federal investigation continues into her April disappearance.

Read more 12
EV Charging Market Grows to $15.2B by 2034 as Infrastructure Expands
📅 in about 2 hours

EV Charging Market Grows to $15.2B by 2034 as Infrastructure Expands

Grid-integrated EV charging market projected to reach $15.2B by 2034 at 10.1% CAGR, with ultra-fast infrastructure growing 16.3% annually.

Read more 12
NVIDIA Corp (NVDA -0.22% / -1.78% Pre-Market) Leads AI Chip Stocks Drop as AMD (-3.02%), Intel (-2.13%), and Micron (-1.41%) Decline 
📅 20 minutes ago

NVIDIA Corp (NVDA -0.22% / -1.78% Pre-Market) Leads AI Chip Stocks Drop as AMD (-3.02%), Intel (-2.13%), and Micron (-1.41%) Decline 

NVIDIA shares fell 1.78% in pre-market trading on June 10, 2026, leading a broader decline across AI chip stocks. AMD dropped 3.02%, while Intel and Micron also traded lower as investors reacted to renewed concerns over inflation, interest rates, and technology valuations.  The selloff comes after a powerful AI-driven rally that pushed semiconductor stocks to…

Read more 12
ETH-USD Market Update: Ethereum Falls -0.98% (-$16.08) to $1,621.55 Amid $24B Open Interest Decline 
📅 41 minutes ago

ETH-USD Market Update: Ethereum Falls -0.98% (-$16.08) to $1,621.55 Amid $24B Open Interest Decline 

The crypto market is once again under pressure, and today’s focus is on Ethereum. Ethereum has dropped 0.98% (-$16.08) to trade around $1,621.55. This move may look small at first glance. But the real story is deeper. A massive $24 billion decline in open interest across ETH derivatives is signaling weakening trader confidence. We are…

Read more 12
Tullamore NSW Town Faces Collapse as Pub Closes, June 10
📅 2 hours ago

Tullamore NSW Town Faces Collapse as Pub Closes, June 10

NSW town Tullamore faces decline after pub closure, with 500 residents and shuttered businesses threatening further economic collapse.

Read more 12
FTSE 100 Rises 0.2% as Deal Optimism Offsets US-Iran Escalation Concerns
📅 2 hours ago

FTSE 100 Rises 0.2% as Deal Optimism Offsets US-Iran Escalation Concerns

The FTSE 100 edged 0.2% higher on June 10, 2026, showing resilience even as tensions between the United States and Iran continued to raise concerns across global markets. Investors looked beyond geopolitical risks and focused on growing optimism surrounding potential diplomatic progress and trade-related developments.  Rising oil prices remained in focus, but confidence in a…

Read more 12
European Stocks Edge Higher as Investors Weigh US-Iran Tensions; WH Smith Plunges 16%
📅 2 hours ago

European Stocks Edge Higher as Investors Weigh US-Iran Tensions; WH Smith Plunges 16%

European stocks are holding their footing but only just. On June 10, 2026, the STOXX 600 opened at 621.72 and traded in a range of 621.10 to 625.22, as European shares edged up while investors parsed the fallout from US-Iran tensions with limited conviction across sectors. The FTSE 100 stood at 10,345, and the DAX…

Read more 12
Concord Biotech Shares Jump 5.9% After US FDA Approves Tofacitinib Arthritis Drug
📅 3 hours ago

Concord Biotech Shares Jump 5.9% After US FDA Approves Tofacitinib Arthritis Drug

Shares of Concord Biotech saw strong buying interest after a key global development. The stock rose around 5.9% in recent trading sessions after news of a US FDA approval related to its Tofacitinib-based arthritis drug. The trigger is important. The US Food and Drug Administration (FDA) approval opens doors to the world’s largest pharmaceutical market….

Read more 12

LPRO News FAQ